Edwards Lifesciences Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	1,074	4,175	1,402	1,522	1,503
Depreciation & Amortization	156.6	143.2	122	139.6	134.8
Loss (Gain) From Sale of Assets	-33.9	-3,348	-	-	-
Asset Writedown & Restructuring Costs	40	-	-	55.1	4
Loss (Gain) From Sale of Investments	146.9	-55	-	51.5	-36.8
Stock-Based Compensation	158.1	162.3	139.4	126.8	109.3
Other Operating Activities	-100.6	-287.3	-264.6	-255.3	-127.6
Change in Accounts Receivable	-23	121.2	-141.2	-84.1	-91.1
Change in Inventory	50.7	-256.1	-289	-213.4	19
Change in Accounts Payable	395.1	89.5	146	-21.4	195.2
Change in Income Taxes	-141.8	-186.7	-5.8	-5.6	62
Change in Other Net Operating Assets	-126.4	-27.2	-236.3	-96.9	-39.8
Operating Cash Flow	1,595	542.3	895.8	1,218	1,732
Operating Cash Flow Growth	194.16%	-39.46%	-26.46%	-29.67%	64.29%
Capital Expenditures	-260.2	-252.4	-253	-244.6	-325.8
Cash Acquisitions	-	-1,062	-95.2	-	-
Divestitures	42.5	3,927	-	-	-
Sale (Purchase) of Intangibles	-	-30	-13.3	-20.2	-4
Investment in Securities	-321.8	-148.5	624.5	689.8	-1,350
Other Investing Activities	-173.4	-121.8	-89.2	-172.7	-42.6
Investing Cash Flow	-712.9	2,313	173.8	252.3	-1,723
Long-Term Debt Issued	-	-	-	-	5.2
Long-Term Debt Repaid	-	-	-	-	-7
Net Debt Issued (Repaid)	-	-	-	-	-1.8
Issuance of Common Stock	174.1	179.5	169.9	146.4	158.6
Repurchase of Common Stock	-893.4	-1,159	-879.6	-1,727	-512.8
Other Financing Activities	-237.5	-3.1	-1.3	-3.8	-0.3
Financing Cash Flow	-956.8	-983	-711	-1,585	-356.3
Foreign Exchange Rate Adjustments	-44.8	38.6	16.8	19.2	13.9
Net Cash Flow	-119.3	1,911	375.4	-94.8	-332.8
Free Cash Flow	1,335	289.9	642.8	973.6	1,406
Free Cash Flow Growth	360.50%	-54.90%	-33.98%	-30.77%	117.26%
Free Cash Flow Margin	22.00%	5.33%	12.83%	21.81%	26.88%
Free Cash Flow Per Share	2.28	0.48	1.05	1.56	2.23
Cash Interest Paid	20.2	19.6	19.9	19.3	20.2
Cash Income Tax Paid	490.4	1,166	444.9	466.7	182.5
Levered Free Cash Flow	1,170	1,339	566.93	776.73	1,009
Unlevered Free Cash Flow	1,182	1,351	577.93	788.73	1,020
Change in Working Capital	154.6	-259.3	-526.3	-421.4	145.3

Source: S&P Global Market Intelligence. Standard template. Financial Sources.